Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: Role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6593-6600

  Sugiura, Tomoko ^a   Kawaguchi, Yasushi ^a   Harigai, Masayoshi ^a   Takagi, Kae ^a   Ohta, Shuji ^a   Fukasawa, Chikako ^a   Hara, Masako ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOMYOSITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MALE; POLYMYOSITIS; PRIORITY JOURNAL;

EID: 0034659757     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.12.6593     Document Type: Article

References (54)

1. O'Hanlon, T. P., and F. W. Miller. 1995. T cell-mediated immune mechanisms in myositis. Curr. Opin. Rheumatol. 7:503.
2. Engel, A. G., and K. Arahata. 1984. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann. Neurol. 16:209.
3. De Bleecker, J. L., and A. G. Engel. 1994. Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy. J. Neuropathol. Exp. Neurol. 53:369.
4. De Bleecker, J. L., and A. G. Engel. 1995. Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies. Am. J. Pathol. 146:1178.
5. Mantegazza, R., F. Andreette, P. Bernasconi, F. Baggi, J. R. Oksenberg, O. Simoncini, M. Mora, F. Cornelio, and L. Steinman. 1993. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. J. Clin. Invest. 91:2880.
6. O'Hanlon, T. P., M. C. Dalakas, P. H. Plotz, and F. W. Miller. 1994. Predominant TCR-αβ variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J. Immunol. 15:2569.
7. Hohlfeld, R., and A. G. Engel. 1991. Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies. Ann. Neurol. 29:498.
8. Curnow, S. J., N. Willcox, and A. Vincent. 1998. Induction of primary immune responses by allogenic human myoblasts: dissection of the cell types required for proliferation. IFNγ secretion and cytotoxicity. J. Neuroimmunol. 86:53.
9. Bartoccioni, E., S. Gallucci, F. Scuderi, E. Ricci, S. Servidei, A. Broccolini, and P. Tonali. 1994. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin. Exp. Immunol. 95:166.
10. Tews, D. S., and H. H. Goebel. 1995. Expression of cell adhesion molecules in inflammatory myopathies. J. Neuroimmunol. 59:185.
11. Behrens, L., A. Bender, M. A. Johnson, and R. Hohlfeld. 1997. Cytotoxic mechanisms in inflammatory myopathies: co-expression of Fas and protective bcl-2 in muscle fibers and inflammatory cells. Brain 120:929.
12. Sugiura, T., Y. Murakawa, A. Nagai, M. Kondo, and S. Kobayashi. 1999. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies. Arthritis Rheum. 42:291.
13. Behrens L., M. Kerschensteiner, T., Misgeld, N., Goebels, H. Wekerle, and R. Hohlfeld. 1998. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and inflammatory lesions. J. Immunol. 161:5943.
14. Paulie, S., B. Ehlin-Henriksson, H. Mellstedt, H. Koho, H. Ben-Aissa, and P. Perlmann. 1985. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother. 20:23.
15. Clark, E. A., and J. A. Ledbetler. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83:4494.
16. + T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175:1091.
17. Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550.
18. Liu, Y. J., J. A. Cairns, M. J. Holder, S. D. Abbot, K. U. Jansen, J. Y. Bonnefoy, J. Gordon, and I. C. M. MacLennan. 1991. Recombinant 25-kDa CD23 and interleukin1a promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol. 21:1107.
19. Yellin, M. J., S. Winikoff, S. M. Fortune, D. Baum, M. K. Crow, S. Lederman, and L. Chess. 1995. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J. Leukocyte Biol. 58:209.
20. Fries, K. M., G. D. Sempowski, A. A. Gaspari, T. Blieden, R. J. Looney, and R. P. Phipps. 1995. CD40 expression by human fibroblasts. Clin. Immunol. Immunopathol. 77:42.
21. Dongari-Bagtzoglou, A. I., W. D. Warren, M. T. Berton, and J. L. Ebersole. 1997. CD40 expression by gingival fibroblasts: correlation of phenotype with function. Int. Immunol. 9:1233.
22. Galy, A. H., and H. Spits. 1992. CD40 is functionally expressed in human thymic epithelial cells. J. Immunol. 149:775.
23. Karmann, K., C. C. W. Hughes, J. Schechner, W. C. Fanslow, and J. S. Pober. 1995. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 9:342.
24. Yellin, M. J., J. Brett, D. Baum, A. Matsushima, M. Szabolcs, D. Stern, and L. Chess. 1995. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 18:1857.
25. Henn, V., J. R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, G. Muller-Berghaus, and R. A. Kroczek. 1998. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591.
26. Bohan, A., and J. B. Peter. 1975. Polymyositis and dermatomyositis: parts 1 and 2. N. Engl. J. Med. 292:344,403.
27. van Kooten, C., and J. Banchereau. 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1.
28. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. vanKooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
29. Tian, L., R. J. Noelle, and D. A. Lawrence. 1995. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25:306.
30. Rissoan, M. C., C. van Kooten, P. Chomarat, L. Galibert, I. Durand, F. Thivolet-Bejui, P. Miossec, and J. Banchereau. 1996. The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium. Clin. Exp. Immunol. 106:481.
31. Sekine, C., H. Yagita, N. Miyasaka, and K. Okumura. 1998. Expression and function of CD40 in rheumatoid arthritis synovium. J. Rheumatol. 25:1048.
32. Harigai, M., M. Hara, S. Nakazawa, C. Fukasawa, S. Ohta, T. Sugiura, K. Inoue, and S. Kashiwazaki. 1999. Ligation of CD40 induced production of tumor necrosis factor-α of synovial tissue cells from patients with rheumatoid arthritis: a novel mechanism of activation of synoviocytes. J. Rheumatol. 26:1035.
33. Fanslow, W. C., S. Srinivasan, R. Paxton, M. G. Gibson, M. K. Spriggs, and R. J. Armitage. 1994. Structural characteristics of CD40 ligand that determine biological function. Semin. Immunol. 6:267.
34. Yoshimura, T., K. Matsushima, S. Tanaka, E. A. Robinson, E. Appella, J. J. Oppenheim, and E. J. Leonard. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84:9233.
35. Matsushima, K., C. G. Larsen, G. DuBois, and J. J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169:1485.
36. Butcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033.
37. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827.
38. Mastumoto, T. K. Ikeda, N. Mukaida, A. Harada, Y. Matsumoto, J. Yamashita, and K. Matsushima. 1997. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest. 77:119.
39. Rand, M. L., J. S. Warren, M. K. Mansour, W. Newman, and D. Ringler. 1996. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1. Am. J. Pathol. 148:855.
40. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, et al. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965.
41. Wilkinson, P. C., and F. Y. Liew. 1995. Chemoattraction of human blood T lymphocytes by interleukin-15. J. Exp. Med. 181:1255.
42. Armitage, R., B. M. Macduff, J. Eisenman, R. Paxton, and K. H. Grabstein. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:483.
43. Quinn, L. S., K. L. Haugk, and K. H. Grabstein. 1995. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 136:3669.
44. Quinn, L. S., K. L. Haugk, and S. E. Damon. 1997. Interleukin-15 stimulates C2 skeletal myoblast differentiation. Biochem. Biophys. Res. Commun. 239:6.
45. Bamford, R. N., A. P. Battiata, J. D. Burton, H. Sharma, and T. A. Waldmann. 1996. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I R region/ IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation. Proc. Natl. Acad. Sci. USA 93:2897.
46. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1.
47. Durie, F. H., R. A. Fava, T. M. Foy, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328.
48. Early, G. S., W. Zhao, and C. M. Burns. 1996. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand Black X New Zealand White mice. J. Immunol. 15:3159.
49. Kalled, S. L., A. H. Cutler, S. K. Datta, and D. W. Thomas. 1998. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J. Immunol. 160:2158.
50. Tews, D. S., and H. H. Goebel. 1996. Cytokine expression profile in idiopathic inflammatory myopathies. J. Neuropathol. Exp. Neurol. 55:342.
51. Lundberg, I., A. K. Ulfgren, P. Nyberg, U. Andersson, and L. Klareskog. 1997. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40:865.
52. Lepidi, H., V. Frances, D. Figarella-Branger, C. Bartoli, A. Machado-Baeta, and J. F. Pellissier. 1998. Local expression of cytokines in idiopathic inflammatory myopathies. Neuropath. Appl. Neurobiol. 24:73.
53. Tateyama, M., I. Nagano, M. Yoshioka, K. Chida, S. Nakamura, and Y. Itoyama. 1997. Expression of tumor necrosis factor-α in muscles in polymyositis. J. Neurol. Sci. 146:45.
54. Lane, P., A. Traunecker, S. Hubele, S. Inui, A. Lanzavecchia, and D. Gray. 1992. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22:2573.